China CAS:175865-59-5 Manufacturer

We're looking forward to welcoming you!

CPHI China will be staged at Shanghai New International Expo Center on June 24-26, 2025 together with ICSE & PMEC China,our booth number is W1G20(b).

At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

Finasteride is one of the most widely researched and prescribed medications for treating male pattern hair loss and benign prostatic hyperplasia (BPH). By targeting the hormonal pathways responsible for hair follicle miniaturization and prostate enlargement, Finasteride has become a cornerstone pharmaceutical ingredient in dermatology and urology. This in-depth guide explores how Finasteride works, its benefits, dosage, safety profile, side effects, comparisons with alternatives, and why global pharmaceutical manufacturers such as Humanwell play a crucial role in its production and supply.

Dutasteride is a powerful 5α-reductase inhibitor widely used in the treatment of benign prostatic hyperplasia (BPH) and increasingly discussed for male pattern hair loss. This article provides a comprehensive overview of what Dutasteride is, how it works at the biochemical level, its benefits, risks, clinical applications, and how it compares with other therapies such as Finasteride.

In recent years, Epiandrosterone has gained increasing attention in biochemical research, pharmaceutical development, and hormone metabolism studies. As a naturally occurring androgen metabolite, this compound plays an important role in steroid biosynthesis and endocrine pathways. Scientists and manufacturers are exploring its potential applications in hormone research, biochemical analysis, and advanced pharmaceutical intermediates.